Empower Advisory Group, LLC
Source: SEC Form 13F · as of Mar 2026Empower Advisory Group, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $1.09B in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$1.09B
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 259,772 | $238.9M |
| JNJJOHNSON & JOHNSON | 897,518 | $219.4M |
| PFEPFIZER INC | 5,626,122 | $158.0M |
| AMGNAMGEN INC | 342,412 | $120.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 442,159 | $119.6M |
| ABBVAbbVie Inc. | 514,594 | $111.9M |
| ABTABBOTT LABORATORIES | 948,125 | $97.3M |
| MRKMerck & Co., Inc. | 168,610 | $20.3M |
| AZNASTRAZENECA PLC | 5,928 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 6,086 | $848K |
| ELVElevance Health Inc. | 2,722 | $797K |
| PMPhilip Morris International Inc | 4,339 | $717K |
| MCKMcKesson Corporation | 628 | $543K |
| BMYBRISTOL MYERS SQUIBB CO | 7,240 | $439K |
| IDXXIDEXX LABORATORIES INC /DE | 781 | $439K |
| NVSNovartis AG | 1,900 | $290K |
| CAHCardinal Health Inc. | 1,237 | $261K |
| CORCencora Inc. | 804 | $253K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 546 | $244K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,310 | $214K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.